C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes
Open Access
- 18 December 2017
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (1) , 162-167
Abstract
A polymorphism at β57 in some major histocompatibility complex class II (MHCII) alleles of rodents and humans is associated with a high risk for developing type 1 diabetes (T1D). However, a highly diabetogenic insulin B chain epitope within the B:9–23 peptide is presented poorly by these alleles to a variety of mouse and human CD4 T cells isolated from either nonobese diabetic (NOD) mice or humans with T1D. We have shown for both species that mutations at the C-terminal end of this epitope dramatically improve presentation to these T cells. Here we present the crystal structures of these mutated peptides bound to mouse IAg7 and human HLA-DQ8 that show how the mutations function to improve T-cell activation. In both peptide binding grooves, the mutation of B:22R to E in the peptide changes a highly unfavorable side chain for the p9 pocket to an optimal one that is dependent on the β57 polymorphism, accounting for why these peptides bind much better to these MHCIIs. Furthermore, a second mutation of the adjacent B:21 (E to G) removes a side chain from the surface of the complex that is highly unfavorable for a subset of NOD mouse CD4 cells, thereby greatly enhancing their response to the complex. These results point out the similarities between the mouse and human responses to this B chain epitope in T1D and suggest there may be common posttranslational modifications at the C terminus of the peptide in vivo to create the pathogenic epitopes in both species. Significance Insulin is a target of CD4 T cells in type 1 diabetes in mice and humans. Why the major epitope in the insulin B chain is presented poorly to the diabetogenic CD4 T cells by the disease-associated major histocompatibility class II (MHCII) alleles has been highly debated. Here we present high-resolution mouse and human MHCII structures and T-cell functional data to show that C-terminal modifications of this epitope are required for binding and presentation in the appropriate position in the MHCII binding groove. These results suggest that pancreas-specific posttranslational modifications of this peptide may play a role in the induction of diabetes and explain how the pathogenic T cells escape deletion in the thymus.Keywords
Funding Information
- Division of Intramural Research (AI-18785)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK-032083)
- HHS | NIH | National Institute of Environmental Health Sciences (ES-125797)
- JDRF (1-PNF-2015-126-A-R)
- Division of Intramural Research (AI-118688)
- CU | University of Colorado Denver (KL2 TR001080)
- HHS | NIH | National Institute of General Medical Sciences (GM-103403)
This publication has 42 references indexed in Scilit:
- T-cell receptor (TCR) interaction with peptides that mimic nickel offers insight into nickel contact allergyProceedings of the National Academy of Sciences, 2012
- Germline TRAV5D-4 T-Cell Receptor Sequence Targets a Primary Insulin Peptide of NOD MiceDiabetes, 2012
- Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disordersCurrent Opinion in Immunology, 2011
- Register shifting of an insulin peptide–MHC complex allows diabetogenic T cells to escape thymic deletionJournal of Experimental Medicine, 2011
- Specificity and detection of insulin-reactive CD4+T cells in type 1 diabetes in the nonobese diabetic (NOD) mouseProceedings of the National Academy of Sciences, 2011
- Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4–HLA-DR1 complexProceedings of the National Academy of Sciences, 2011
- Diabetogenic T cells recognize insulin bound to IAg7in an unexpected, weakly binding registerProceedings of the National Academy of Sciences, 2010
- Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificityJournal of Clinical Investigation, 2005
- Genetic prediction of autoimmunity: Initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4–DQ8 relatives of patients with type 1A diabetesJournal of Autoimmunity, 2005
- Analysis of the Spontaneous T Cell Response to Insulin in NOD MiceJournal of Autoimmunity, 1994